title: Neurosteroids ameliorate conditioned fear stress: an association with sigma receptors.
abstract: Mice exhibited a marked suppression of motility (conditioned fear stress) when placed in an environment in which they had previously received an electric footshock. This conditioned fear stress response was dose-dependently attenuated by neurosteroids such as dehydroepiandrosterone sulfate (DHEAS; 25 and 50 mg/kg, s.c.) and pregnenolone sulfate (PREGS; 10-50 mg/kg, s.c.), and by a putative sigma(1) receptor agonist, (+)-N-allylnormetazocine ((+)-SKF-10,047; 3 and 6 mg/kg, s.c.). However, progesterone (PROG; 10-50 mg/kg, s.c. ) and allopregnanolone (5 and 20 mg/kg, s.c.) had no effect on this stress response. The attenuating effects of DHEAS (50 mg/kg, s.c.), PREGS (50 mg/kg, s.c.), and (+)-SKF-10,047 (6 mg/kg, s.c.) were reversed by NE-100 (5 mg/kg, i.p.), a sigma(1) receptor antagonist and PROG (5 or 10 mg/kg, i.p.). When DHEAS (25 mg/kg) was co-administered with (+)-SKF-10,047 (3 mg/kg) at doses that do not affect the conditioned fear stress response by themselves, motor suppression was significantly attenuated. In mice showing the conditioned fear stress response, the serum concentration of DHEAS was lower than that in non-shocked mice. These results suggest that the attenuating effects of DHEAS and PREGS on the conditioned fear stress response are mediated via sigma(1) receptors and that PROG has a sigma(1) receptor antagonistic property. Further, the endogenous DHEAS may be involved in the expression of conditioned fear stress response in mice.
authors.affiliation: Department of Neuropsychopharmacology and Hospital Pharmacy, Nagoya University Graduate School of Medicine, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Noda
authors.forename: H
authors.initials: H
authors.lastname: Kamei
authors.forename: Y
authors.initials: Y
authors.lastname: Kamei
authors.forename: T
authors.initials: T
authors.lastname: Nagai
authors.forename: M
authors.initials: M
authors.lastname: Nishida
authors.forename: T
authors.initials: T
authors.lastname: Nabeshima
mesh_terms: D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology; D003213:Conditioning, Psychological / Q000502:physiology; D019314:Dehydroepiandrosterone Sulfate / Q000097:blood / Q000494:pharmacology; D004597:Electroshock; D005239:Fear / Q000187:drug effects* / Q000523:psychology; D008297:Male; D051379:Mice; D010620:Phenazocine / Q000031:analogs & derivatives / Q000494:pharmacology; D011284:Pregnenolone / Q000494:pharmacology; D017480:Receptors, sigma / Q000037:antagonists & inhibitors / Q000187:drug effects*; D013256:Steroids / Q000494:pharmacology*; D013315:Stress, Psychological / Q000523:psychology*; D000097605:Sigma-1 Receptor
chemical_list: D014150:Antipsychotic Agents; D019314:Dehydroepiandrosterone Sulfate; D010620:Phenazocine; D011284:Pregnenolone; D017480:Receptors, sigma; D013256:Steroids; D000097605:Sigma-1 Receptor; C012134:SK&F 10047